Christoph Westphal

Director at Newleos Therapeutics.

Raised on Newleos Therapeutics filings

$93.4M

of $93.4M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Feb 24, 2025

Company

Newleos Therapeutics

Biotech · Boston, MA

Drugs for anxiety and substance use disorders

Drugs for anxiety and substance use disorders

Investors: 11
Founded: 2024

Investors: 11
Sector: Biotech
Founded: 2024
HQ: Boston, MA

Newleos Therapeutics filings

Newleos Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Feb 24, 2025	Equity	$93.4M/ $93.4M	Form D

EquityFiled Feb 24, 2025Form D
$93.4M/ $93.4M

Works with

Also named on Newleos Therapeutics filings

David DonabedianPresident and CEO, Form D signerForm D signer Robert HadfieldExecutive Officer John McCabeExecutive Officer Ming CheahDirector Raymond CamahortDirector